EI
ALBO

Ellevest Inc’s Albireo Pharma Inc ALBO Stock Holding History

Ellevest Inc’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21
Closed – – 1996
2022
Q3 		$0 Buy
21
+15
+250% +$310 ﹤0.01% 1964
2022
Q2 		$0 Hold
6
– – ﹤0.01% 1803
2022
Q1 		$0 Hold
6
– – ﹤0.01% 1705
2021
Q4 		$0 Hold
6
– – ﹤0.01% 1737
2021
Q3 		$0 Hold
6
– – ﹤0.01% 1644
2021
Q2 		$0 Sell
6
-4
-40% -$130 ﹤0.01% 1458
2021
Q1 		$0 Hold
10
– – ﹤0.01% 1390
2020
Q4 		$0 Buy
10
+4
+67% +$145 ﹤0.01% 1409
2020
Q3 		$0 Hold
6
– – ﹤0.01% 1369
2020
Q2 		$0 Buy
6
+5
+500% +$118 ﹤0.01% 1407
2020
Q1 		$0 Buy
+1
New +$22 ﹤0.01% 1360

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Ellevest Inc's ALBO Position: Q4 2022 in Review

Ellevest Inc sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 21 shares.

Ellevest Inc first reported a position in ALBO in Q1 2020 and held it in 11 quarters. The position peaked at $0 in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Ellevest Inc reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 21 Albireo Pharma Inc shares in Q4 2022.
  • Ellevest Inc first reported a position in Albireo Pharma Inc in Q1 2020 and held it in 11 quarters.
  • Ellevest Inc's Albireo Pharma Inc position peaked at $0 in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.